<DOC>
	<DOCNO>NCT02026011</DOCNO>
	<brief_summary>This study elucidate pharmacogenetic effect Asn40Asp SNP OPRM1 gene biobehavioral neural marker response naltrexone individual East Asian descent , ethnic group likely express positive predictive allele .</brief_summary>
	<brief_title>Naltrexone Individuals East Asian Descent</brief_title>
	<detailed_description>Recent pharmacogenetic study advance gene cod µ-opioid receptor ( OPRM1 ) gene potential moderator responses naltrexone . The widely study polymorphism OPRM1 gene Asn40Asp single nucleotide polymorphism ( SNP ) , functional mutation think affect receptor activity Asp40 variant bind β-endorphin three time strong Asn40 allele . Recent study find Asp40 carrier strong striatal dopamine response intravenous alcohol administration report strong feeling alcohol reward . Findings COMBINE Study demonstrate treated Medication Management alone naltrexone , 87.1 % Asp40 carrier good clinical outcome , compare 54.8 % Asn40 homozygotes . While finding promise , study also highlight allele frequency imbalance function ethnicity Asp40 allele frequency approximately 20 % Caucasians , 5 % individual African Ancestry , high 50 % among individual East Asian descent . Therefore , extent SNP moderate behavioral clinical response NTX , ethnicity must carefully consider order extend finding primarily Caucasian sample ethnic minority , Asian Americans . Preliminary work team find among individual East Asian descent , Asp40 carriers show great NTX-induced blunting alcohol crave well potentiation aversive effect alcohol . This pilot study also find support gene dose-response , Asp40Asp individual show great NTX responsivity Asn40Asp genotype . This study seek build upon preliminary finding test heavy drinker East Asian descent across three OPRM1 genotype ( Asn40Asn , n = 30 ; Asn40Asp , n = 30 , Asp40Asp , n = 30 ) . Participants complete two double-blinded , counterbalanced alcohol infusion self-administration session , one take NTX ( 50 mg/day ) one take match placebo five day . In medication condition , participant complete functional neuroimaging task examine cue-induced craving alcohol . This study elucidate pharmacogenetic effect Asn40Asp SNP OPRM1 gene biobehavioral neural marker response naltrexone individual Asian descent , ethnic group likely express positive predictive allele ( Asp40 ) . The long-term objective research optimize alcoholism pharmacotherapy address health disparity advance pharmacogenetic study ethnic minority group .</detailed_description>
	<mesh_term>Alcohol Drinking</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>current ( i.e. , past month ) alcohol dependence East Asian ethnicity ( i.e. , Chinese , Korean , Japanese ) Prospective genotyping A118G SNP mu opioid receptor ( OPRM1 ) gene allow balance group three genotype ( AA , AG , GG ) lifetime DSMIV drug dependence ( alcohol nicotine ) current use psychoactive drug determine selfreports verify use toxicology test lifetime diagnosis bipolar disorder psychotic disorder contraindication MRI scan ( include leave handedness )</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>alcohol use disorder</keyword>
	<keyword>naltrexone</keyword>
	<keyword>Asian American</keyword>
	<keyword>pharmacogenetics</keyword>
	<keyword>OPRM1 gene</keyword>
</DOC>